Search Results - "Qian, Kewen"
-
1
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
Published in Nature communications (24-04-2020)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, at the end of 2019, and there are currently no specific antiviral…”
Get full text
Journal Article -
2
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
Published in Nature communications (25-09-2019)“…Genetically engineered T cells expressing a chimeric antigen receptor (CAR) are rapidly emerging a promising new treatment for haematological and…”
Get full text
Journal Article -
3
The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapy
Published in Journal of experimental & clinical cancer research (27-09-2022)“…Abstract Extracellular vesicles (EVs) facilitate the extracellular transfer of proteins, lipids, and nucleic acids and mediate intercellular communication…”
Get full text
Journal Article -
4
Ig-like ACE2 protein therapeutics: A revival in development during the COVID-19 pandemic
Published in mAbs (01-01-2020)“…While the potential therapeutic utility of angiotensin-converting enzyme 2 (ACE2) is well established, the clinical development of ACE2 drugs has been limited,…”
Get full text
Journal Article -
5
CAR Macrophages for SARS-CoV-2 Immunotherapy
Published in Frontiers in immunology (23-07-2021)“…Targeted therapeutics for the treatment of coronavirus disease 2019 (COVID-19), especially severe cases, are currently lacking. As macrophages have unique…”
Get full text
Journal Article -
6
Engineered soluble ACE2 receptor: Responding to change with change
Published in Frontiers in immunology (18-01-2023)“…SARS coronavirus 2 (SARS-CoV-2) invades the human body by binding to major receptors such as ACE2 its S-spike protein, so the interaction of receptor-binding…”
Get full text
Journal Article -
7
The therapeutic potential of exosomes in immunotherapy
Published in Frontiers in immunology (08-07-2024)“…Exosomes are found in various tissues of the body and carry abundant contents including nucleic acids, proteins, and metabolites, which continuously flow…”
Get full text
Journal Article -
8
Small extracellular vesicles purification and scale-up
Published in Frontiers in immunology (26-02-2024)“…Exosomes are small extracellular vesicles (sEVs) secreted by cells. With advances in the study of sEVs, they have shown great potential in the diagnosis and…”
Get full text
Journal Article -
9
CAR‐T‐cell products in solid tumors: Progress, challenges, and strategies
Published in Interdisciplinary medicine (Richmond, Vic. Print) (01-04-2024)“…T cells engineered to express chimeric antigen receptors (CARs) with specificity toward tumor cells have led to promising outcomes in patients with…”
Get full text
Journal Article -
10
Therapeutic antibodies under development for SARS‐CoV‐2
Published in View (Beijing, China) (01-03-2022)“…The world is experiencing one of the most difficult moments in history with COVID‐19, which has rapidly developed into a worldwide pandemic with a significant…”
Get full text
Journal Article -
11
Development and characterization of a novel neutralizing scFv vectored immunoprophylaxis against botulinum toxin type A
Published in Journal of drug targeting (01-12-2024)“…Botulinum toxin is a protein toxin secreted by Clostridium botulinum that is strongly neurotoxic. Due to its characteristics of being super toxic, quick…”
Get full text
Journal Article -
12
Exosomes derived from cancer cells relieve inflammatory bowel disease in mice
Published in Journal of drug targeting (01-11-2024)“…Exosome therapy has garnered significant attention due to its natural delivery capabilities, low toxicity, high biocompatibility, and potential for…”
Get full text
Journal Article -
13
Bispecific antibodies targeting EGFR/Notch enhance the response to talazoparib by decreasing tumour-initiating cell frequency
Published in Theranostics (01-01-2023)“…Poly ADP ribose polymerase (PARP) inhibitors are mainly used in treating BRCA-mutant cancers, and their application in novel therapies to expand their benefit…”
Get full text
Journal Article -
14
The application of antibody-based agents in cancer therapy based on their mechanisms of action
Published in Fundamental research (Beijing) (01-04-2024)Get full text
Journal Article -
15
Back Cover: Therapeutic antibodies under development for SARS‐CoV‐2 (View 2/2022)
Published in View (Beijing, China) (01-03-2022)“…Research on antibody therapy for SARS‐COV‐2 is in the ascendant, including single antibody therapy and multiple antibody combinations. The multi‐drug…”
Get full text
Journal Article